My concern is there are so many obese Americans, who have various medical issues as a result, that adding a new drug to the mix might have traumatic results.
(PRWEB) August 19, 2012
Jay Altman, of Altman Fitness, is announcing his concerns about the FDA’s approval of Qsymia. Qsymia, previously known as Qnexa, was developed by Vivus of Mountain View, Calif. According to the New York Times, Qsymia is the second new drug for obesity approved in the last month. But, Altman fears the public will rely on Qsymia as an “easy out” option to traditional diet and exercise.
“The short and long term effects of any traditional diet and exercise program, like the one Altman Fitness offers called the 28 Day Fat Loss Formula plan, far outweigh the results and safety of the latest drugs for obesity, such as Qsymia,” says Jay Altman of Altman Fitness. “We know 28 days will be enough to start someone on a safer, more effective solution to weight loss than any fad drug. My concern is there are so many obese Americans, who have various medical issues as a result, that adding a new drug to the mix might be not only a substitute for hard work, but it might have traumatic results on a person’s health long term.”
Altman Fitness offers a 100% guarantee on the company’s weight loss and fitness services. “I stand behind my company and what we offer. And, I stand behind traditional weight loss efforts in general,” Altman continued. “For a while everyone was trending on the Fen-Phen diet. The makers of Fen-Phen ended up paying $21.1 billion (U.S.) to cover the cost of the lawsuits resulting from the serious health conditions that resulted from use of the drug. Any drug designed to help someone lose weight has to be carefully considered. I say try the traditional route first.”
More information on Altman Fitness’ 28 Day Fat Loss Forumla Plan can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/